Data / Medical devices / Thailand / Hoya Lamphun Ltd.
Hoya Lamphun Ltd.: FDA-registered device maker in Amphur Muang Lamphun, Thailand, 1 PMA approval
Hoya Lamphun Ltd. is registered with the FDA (registration 3020977988) in Amphur Muang Lamphun, Thailand. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated September 26, 2008. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3020977988
- Address
- 75/2 Moo 4, Tambol Banklang, Amphur Muang Lamphun, Thailand, 51000
- Owner or operator
- HOYA MEDICAL SINGAPORE PTE LTD (10026402)
- Roles
- Manufacturer
- First device listed
- October 13, 2008
- Registered through
- 2026
- Brand names listed
- IPure B1PC, IPure B1PY, IPure B3PC, IPure B3PY, PreVue C, PreVue Y, ezSert 254E, ezSert 255E and more
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Intraocular Lens | HQL | 3 | Manufacturer | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| September 26, 2008 | P080004 | HOYA ISPHERIC MODEL YA-60BB INTRAOCULAR LENS | HQL | 45 | October 25, 2023 | accessdata.fda.gov |
Compare with other makers
Updated October 25, 2023. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.